NVWM LLC’s Gilead Sciences GILD Stock Holding History

NVWM LLC’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.06K	Hold	48	–	–	﹤0.01%	347
2026 Q1	$6.69K	Hold	48	–	–	﹤0.01%	329
2025 Q4	$5.89K	Buy	48 +10	+26%	+$1.22K	﹤0.01%	342
2025 Q3	$4.22K	Hold	38	–	–	﹤0.01%	361
2025 Q2	$4.21K	Buy	38 +5	+15%	+$532	﹤0.01%	354
2025 Q1	$3.7K	Buy	33 +5	+18%	+$516	﹤0.01%	338
2024 Q4	$2.59K	Buy	28 +10	+56%	+$900	﹤0.01%	357
2024 Q3	$1.51K	Buy	18 +5	+38%	+$382	﹤0.01%	413
2024 Q2	$892	Sell	13 -4	-24%	-$267	﹤0.01%	462
2024 Q1	$1.25K	Buy	+17	New	+$1.31K	﹤0.01%	385
2022 Q2	–	Sell	-53	Closed	-$3K	–	493
2022 Q1	$3K	Buy	+53	New	+$3.39K	﹤0.01%	469
2021 Q1	–	Sell	-100	Closed	-$6K	–	424
2020 Q4	$6K	Buy	+100	New	+$6.03K	﹤0.01%	312
2020 Q2	–	Sell	-7,253	Closed	-$542K	–	356
2020 Q1	$542K	Buy	+7,253	New	+$501K	0.38%	79
2018 Q2	–	Sell	-6,188	Closed	-$453K	–	365
2018 Q1	$453K	Buy	6,188 +139	+2%	+$11.1K	0.33%	98
2017 Q4	$433K	Buy	+6,049	New	+$459K	0.33%	98

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NVWM LLC's GILD Position: Q2 2026 in Review

NVWM LLC held its Gilead Sciences (GILD) position steady in Q2 2026 at 48 shares worth $6.06K. The position accounts for ﹤0.01% of the portfolio, ranked #347.

NVWM LLC first reported a position in GILD in Q4 2017 and has held it in 15 quarters since. The position peaked at $542K in Q1 2020. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

NVWM LLC held 48 shares of Gilead Sciences worth $6.06K as of Q2 2026.
NVWM LLC left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up ﹤0.01% of NVWM LLC's portfolio in Q2 2026, its #347 holding.
NVWM LLC first reported a position in Gilead Sciences in Q4 2017 and has held it in 15 quarters since.
NVWM LLC's Gilead Sciences position peaked at $542K in Q1 2020.
2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on NVWM LLC's 13F filing for Q2 2026, filed 29 Jul 2026.